IDRAC
Three new country modules — India, Israel and Turkey — are now available in IDRAC, the global pharmaceutical regulatory intelligence database from Thomson Scientific.
Three new country modules — India, Israel and Turkey — are now available in IDRAC, the global pharmaceutical regulatory intelligence database from Thomson Scientific.
BioMed Central has launched an open-access journal focusing on the emerging subject of systems biology.
Nature Publishing Group (NPG) has launched two new freely-available information resources. The Functional Glycomics Gateway is a collaboration between the Consortium for Functional Glycomics…
The EMBO Journal and EMBO reports, which are published by Nature Publishing Group, will accept open-access articles as of January 2007, subject to payment…
All papers in Plant Physiology by American Society of Plant Biologists (ASPB) members are to be published with full open access.
HFSP Publishing is launching the HFSP Journal, Frontiers of Interdisciplinary Research in the Life Sciences to foster communication between scientists publishing innovative interdisciplinary research…
Cell Press is launching Cell Hose & Microbe, which will focus on the interactions between microbes and their hosts.
John Wiley & Sons has been selected by the International Union of Biochemistry and Molecular Biology (IUBMB) to publish Biochemistry and Molecular Biology Education
Ovid has expanded its partnership with Oxford University Press (OUP) to add more than 180 titles in medicine, neurosciences, social and behavioural sciences to…
International Journal of Biomedical Sciences (IJBS) is a new quarterly, open-access journal focusing on theories, methods and applications in biomedical sciences, computational and systems…
Springer has entered into a partnership with the Society for In Vitro Biology and the International Association for Plant Biotechnology to publish two In…
Text analytics provider TEMIS has introduced the first industry-specific edition of its recently launched information intelligence solution, Luxid. The first industry targeted is life…